Discovery of a Metabolic Signature Predisposing High Risk Patients with Mild Cognitive Impairment to Converting to Alzheimer’s Disease

Cardiolipin, Mitochondria, and Neurological Disease

(2021) Micol Falabella et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Blood biomarkers indicate that the preclinical stages of Alzheimer's disease present overlapping molecular features

(2020) Alfonso Di Costanzo et al.   Scientific Reports

Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics

(2019) Yogatheesan Varatharajah et al.   Scientific Reports

Metabolomics in the Development and Progression of Dementia: A Systematic Review

(2019) Yanfeng Jiang et al.   Frontiers in Neuroscience

Multi-Omic Analysis of the Microbiome and Metabolome in Healthy Subjects Reveals Microbiome-Dependent Relationships Between Diet and Metabolites

(2019) Zheng-Zheng Tang et al.   Frontiers in Genetics

Computational Methods for the Discovery of Metabolic Markers of Complex Traits

(2019) Michael Lee et al.   Metabolites

Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota

(2019) Binyin Li et al.   Alzheimers & Dementia

Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study

(2018) Vijay R. Varma et al.   PLOS MEDICINE

Cardiolipin Profile Changes are Associated to the Early Synaptic Mitochondrial Dysfunction in Alzheimer's Disease

(2018) Vera F. Monteiro-Cardoso et al.   JOURNAL OF ALZHEIMERS DISEASE

Microbial tryptophan catabolites in health and disease

(2018) Henrik M. Roager et al.   Nature Communications

Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic

(2018) Harald Hampel et al.   Nature Reviews Neurology

Cinnamic acid activates PPARα to stimulate Lysosomal biogenesis and lower Amyloid plaque pathology in an Alzheimer's disease mouse model

(2018) Sujyoti Chandra et al.   NEUROBIOLOGY OF DISEASE

Why do trials for Alzheimer’s disease drugs keep failing? A discontinued drug perspective for 2010-2015

(2017) Dev Mehta et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Polyphenols journey through blood-brain barrier towards neuronal protection

(2017) I. Figueira et al.   Scientific Reports

Gut microbiome alterations in Alzheimer’s disease

(2017) Nicholas M. Vogt et al.   Scientific Reports

Blood metabolite markers of preclinical Alzheimer's disease in two longitudinally followed cohorts of older individuals

(2016) Ramon Casanova et al.   Alzheimers & Dementia

Does mild cognitive impairment always lead to dementia? A review

(2016) Seema Y. Pandya et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Plasma 24-metabolite Panel Predicts Preclinical Transition to Clinical Stages of Alzheimer’s Disease

(2015) Massimo S. Fiandaca et al.   Frontiers in Neurology

The critical need for defining preclinical biomarkers in Alzheimer's disease

(2014) Massimo S. Fiandaca et al.   Alzheimers & Dementia

Biomarkers in dementia: clinical utility and new directions

(2014) R M Ahmed et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Plasma Metabolite Profiles of Alzheimer’s Disease and Mild Cognitive Impairment

(2014) Gang Wang et al.   JOURNAL OF PROTEOME RESEARCH

Plasma phospholipids identify antecedent memory impairment in older adults

(2014) Mark Mapstone et al.   NATURE MEDICINE

Random Forest in Clinical Metabolomics for Phenotypic Discrimination and Biomarker Selection

(2013) Tianlu Chen et al.   Evidence-based Complementary and Alternative Medicine

A new metabolomic workflow for early detection of Alzheimer's disease

(2013) Clara Ibáñez et al.   JOURNAL OF CHROMATOGRAPHY A

Identification of Altered Metabolic Pathways in Plasma and CSF in Mild Cognitive Impairment and Alzheimer’s Disease Using Metabolomics

(2013) Eugenia Trushina et al.   PLoS One

Reversion from mild cognitive impairment to normal or near-normal cognition: Risk factors and prognosis

(2012) T. D. Koepsell et al.   NEUROLOGY

Predicting Future Clinical Changes of MCI Patients Using Longitudinal and Multimodal Biomarkers

(2012) Daoqiang Zhang et al.   PLoS One

Les nouvelles recommandations 2011 du National Institute on Aging et de l’Alzheimer's Association sur le diagnostic de la maladie d’Alzheimer : stades précliniques, mild cognitive impairment et démence

(2012) B. Croisile et al.   REVUE NEUROLOGIQUE

Metabolome in progression to Alzheimer's disease

(2011) M Orešič et al.   Translational Psychiatry

Blood-based biomarkers of Alzheimer’s disease: challenging but feasible

(2010) Madhav Thambisetty et al.   Biomarkers in Medicine

In silico fragmentation for computer assisted identification of metabolite mass spectra

(2010) Sebastian Wolf et al.   BMC BIOINFORMATICS

Analytical Error Reduction Using Single Point Calibration for Accurate and Precise Metabolomic Phenotyping

(2009) Frans M. van der Kloet et al.   JOURNAL OF PROTEOME RESEARCH